Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 7 | 2022 | 65 | 3.200 |
Why?
|
| Lupus Erythematosus, Systemic | 7 | 2018 | 756 | 1.930 |
Why?
|
| Dendritic Cells | 6 | 2022 | 201 | 1.150 |
Why?
|
| Lupus Nephritis | 3 | 2020 | 193 | 0.890 |
Why?
|
| Interleukin-17 | 1 | 2022 | 62 | 0.850 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2020 | 17 | 0.770 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 11 | 0.730 |
Why?
|
| Autoimmunity | 3 | 2020 | 118 | 0.690 |
Why?
|
| Toll-Like Receptors | 2 | 2022 | 56 | 0.630 |
Why?
|
| Membrane Glycoproteins | 2 | 2020 | 370 | 0.630 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 179 | 0.630 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 171 | 0.580 |
Why?
|
| Spleen | 4 | 2020 | 301 | 0.570 |
Why?
|
| Mice | 9 | 2022 | 8472 | 0.500 |
Why?
|
| Granulosa Cells | 2 | 2004 | 21 | 0.480 |
Why?
|
| Mice, Knockout | 5 | 2018 | 1692 | 0.430 |
Why?
|
| Animals | 13 | 2022 | 20877 | 0.410 |
Why?
|
| Cognition Disorders | 1 | 2014 | 342 | 0.410 |
Why?
|
| Immunity | 1 | 2011 | 67 | 0.380 |
Why?
|
| Receptors, Estrogen | 1 | 2011 | 142 | 0.370 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.360 |
Why?
|
| Transcription Factors | 2 | 2004 | 753 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 2790 | 0.310 |
Why?
|
| Autoantibodies | 2 | 2020 | 434 | 0.280 |
Why?
|
| Cell Nucleus | 2 | 2004 | 305 | 0.280 |
Why?
|
| Estrogens | 3 | 2022 | 173 | 0.260 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 29 | 0.240 |
Why?
|
| Female | 10 | 2022 | 38015 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 194 | 0.220 |
Why?
|
| Cell Cycle | 1 | 2004 | 312 | 0.220 |
Why?
|
| CD11c Antigen | 1 | 2022 | 18 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 2550 | 0.220 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 222 | 0.220 |
Why?
|
| Interferons | 1 | 2022 | 36 | 0.220 |
Why?
|
| Macrophages | 2 | 2020 | 647 | 0.210 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 230 | 0.210 |
Why?
|
| Kidney | 2 | 2017 | 945 | 0.200 |
Why?
|
| Splenomegaly | 1 | 2020 | 13 | 0.180 |
Why?
|
| Interferon Type I | 2 | 2016 | 32 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 329 | 0.180 |
Why?
|
| Complement C3 | 1 | 2018 | 101 | 0.160 |
Why?
|
| Proteinuria | 1 | 2018 | 136 | 0.160 |
Why?
|
| Ovariectomy | 1 | 2017 | 49 | 0.160 |
Why?
|
| Antibody Formation | 1 | 2017 | 93 | 0.150 |
Why?
|
| Testosterone | 1 | 2017 | 96 | 0.150 |
Why?
|
| Biopsy | 1 | 2018 | 539 | 0.140 |
Why?
|
| Estradiol | 1 | 2017 | 176 | 0.140 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 481 | 0.140 |
Why?
|
| Inflammation | 1 | 2022 | 1030 | 0.140 |
Why?
|
| Survival Rate | 1 | 2018 | 1055 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 5 | 0.130 |
Why?
|
| DNA | 1 | 2017 | 597 | 0.130 |
Why?
|
| Mesangial Cells | 1 | 2014 | 37 | 0.130 |
Why?
|
| Maze Learning | 1 | 2014 | 138 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 248 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 175 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 785 | 0.120 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 155 | 0.110 |
Why?
|
| Thrombosis | 1 | 2014 | 218 | 0.110 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.110 |
Why?
|
| Guanosine | 1 | 2012 | 3 | 0.110 |
Why?
|
| CpG Islands | 1 | 2012 | 51 | 0.110 |
Why?
|
| Swine | 2 | 2004 | 672 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2673 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 217 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2020 | 2688 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1663 | 0.090 |
Why?
|
| Cytokines | 1 | 2012 | 866 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 595 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1293 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 22 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 37 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2004 | 51 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 38 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 94 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 63 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 57 | 0.060 |
Why?
|
| Cytosol | 1 | 2003 | 123 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 200 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 331 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 411 | 0.050 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.050 |
Why?
|
| Cell Survival | 1 | 2003 | 901 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2003 | 1199 | 0.050 |
Why?
|
| Male | 2 | 2020 | 37281 | 0.050 |
Why?
|
| Mutation | 1 | 2004 | 1213 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2015 | 35 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 101 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 114 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2014 | 155 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 330 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 186 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 432 | 0.030 |
Why?
|
| Age Factors | 1 | 2014 | 1860 | 0.020 |
Why?
|
| Humans | 2 | 2014 | 68525 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5719 | 0.020 |
Why?
|